Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 91


Patients' needs during a surgical intervention process for Dupuytren's disease.

Turesson C, Kvist J, Krevers B.

Disabil Rehabil. 2017 Nov 21:1-8. doi: 10.1080/09638288.2017.1402095. [Epub ahead of print]


Course of Grip Force Impairment in Patients With Early Rheumatoid Arthritis Over the First Five Years After Diagnosis.

Rydholm M, Book C, Wikström I, Jacobsson L, Turesson C.

Arthritis Care Res (Hoboken). 2017 Jul 10. doi: 10.1002/acr.23318. [Epub ahead of print]


Severe Extraarticular Manifestations in a Community-based Cohort of Patients with Rheumatoid Arthritis: Risk Factors and Incidence in Relation to Treatment with Tumor Necrosis Factor Inhibitors.

Theander L, Nyhäll-Wåhlin BM, Nilsson JÅ, Willim M, Jacobsson LTH, Petersson IF, Turesson C.

J Rheumatol. 2017 Jul;44(7):981-987. doi: 10.3899/jrheum.161103. Epub 2017 May 1.


Cigarette smoking and the risk of primary Sjögren's syndrome: a nested case control study.

Olsson P, Turesson C, Mandl T, Jacobsson L, Theander E.

Arthritis Res Ther. 2017 Mar 7;19(1):50. doi: 10.1186/s13075-017-1255-7.


EQ-5D utility, response and drug survival in rheumatoid arthritis patients on biologic monotherapy: A prospective observational study of patients registered in the south Swedish SSATG registry.

Jørgensen TS, Turesson C, Kapetanovic M, Englund M, Turkiewicz A, Christensen R, Bliddal H, Geborek P, Kristensen LE.

PLoS One. 2017 Feb 2;12(2):e0169946. doi: 10.1371/journal.pone.0169946. eCollection 2017.


Body mass does not impact the clinical response to intravenous abatacept in patients with rheumatoid arthritis. Analysis from the "pan-European registry collaboration for abatacept (PANABA).

Iannone F, Courvoisier DS, Gottenberg JE, Hernandez MV, Lie E, Canhão H, Pavelka K, Hetland ML, Turesson C, Mariette X, Choquette D, Finckh A.

Clin Rheumatol. 2017 Apr;36(4):773-779. doi: 10.1007/s10067-016-3505-5. Epub 2016 Dec 14.


Rate of Comorbidities in Giant Cell Arteritis: A Population-based Study.

Mohammad AJ, Englund M, Turesson C, Tomasson G, Merkel PA.

J Rheumatol. 2017 Jan;44(1):84-90. doi: 10.3899/jrheum.160249. Epub 2016 Nov 1.


Rheumatoid Arthritis Patients after Initiation of a New Biologic Agent: Trajectories of Disease Activity in a Large Multinational Cohort Study.

Courvoisier DS, Alpizar-Rodriguez D, Gottenberg JE, Hernandez MV, Iannone F, Lie E, Santos MJ, Pavelka K, Turesson C, Mariette X, Choquette D, Hetland ML, Finckh A.

EBioMedicine. 2016 Sep;11:302-306. doi: 10.1016/j.ebiom.2016.08.024. Epub 2016 Aug 18.


The effect of clinical features and glucocorticoids on biopsy findings in giant cell arteritis.

Jakobsson K, Jacobsson L, Mohammad AJ, Nilsson JÅ, Warrington K, Matteson EL, Turesson C.

BMC Musculoskelet Disord. 2016 Aug 24;17(1):363. doi: 10.1186/s12891-016-1225-2.


Large vessel involvement in biopsy-proven giant cell arteritis: incidence, distribution, and predictors.

Naderi N, Mohammad AJ, Turesson C.

Scand J Rheumatol. 2017 May;46(3):215-221. doi: 10.1080/03009742.2016.1190984. Epub 2016 Jul 6.


Visual Complications in Patients with Biopsy-proven Giant Cell Arteritis: A Population-based Study.

Saleh M, Turesson C, Englund M, Merkel PA, Mohammad AJ.

J Rheumatol. 2016 Aug;43(8):1559-65. doi: 10.3899/jrheum.151033. Epub 2016 Jun 1.


Multiplex cytokine analyses in patients with rheumatoid arthritis require use of agents blocking heterophilic antibody activity.

Olsson P, Theander E, Bergström U, Jovinge S, Jacobsson L, Turesson C.

Scand J Rheumatol. 2017 Jan;46(1):1-10. doi: 10.3109/03009742.2016.1161070. Epub 2016 May 12.


Comorbidity in rheumatoid arthritis.

Turesson C.

Swiss Med Wkly. 2016 Apr 5;146:w14290. doi: 10.4414/smw.2016.14290. eCollection 2016. Review.


A multicentre, randomised, controlled, open-label pilot study on the feasibility of discontinuation of adalimumab in established patients with rheumatoid arthritis in stable clinical remission.

Chatzidionysiou K, Turesson C, Teleman A, Knight A, Lindqvist E, Larsson P, Cöster L, Forslind K, van Vollenhoven R, Heimbürger M.

RMD Open. 2016 Jan 14;2(1):e000133. doi: 10.1136/rmdopen-2015-000133. eCollection 2016.


Brief Report: Association of Rheumatoid Factor and Anti-Citrullinated Protein Antibody Positivity With Better Effectiveness of Abatacept: Results From the Pan-European Registry Analysis.

Gottenberg JE, Courvoisier DS, Hernandez MV, Iannone F, Lie E, Canhão H, Pavelka K, Hetland ML, Turesson C, Mariette X, Finckh A.

Arthritis Rheumatol. 2016 Jun;68(6):1346-52. doi: 10.1002/art.39595.


Parity influences the severity of ACPA-negative early rheumatoid arthritis: a cohort study based on the Swedish EIRA material.

Pikwer M, Orellana C, Källberg H, Pikwer A, Turesson C, Klareskog L, Alfredsson L, Saevarsdottir S, Bengtsson C.

Arthritis Res Ther. 2015 Dec 12;17:358. doi: 10.1186/s13075-015-0869-x.


The impact of patient heterogeneity and socioeconomic factors on abatacept retention in rheumatoid arthritis across nine European countries.

Finckh A, Neto D, Iannone F, Loza E, Lie E, van Riel P, Hetland ML, Pavelka K, Gottenberg JE, Canhão H, Mariette X, Turesson C.

RMD Open. 2015 Apr 30;1(1):e000040. doi: 10.1136/rmdopen-2014-000040. eCollection 2015.


High serum cholesterol predicts rheumatoid arthritis in women, but not in men: a prospective study.

Turesson C, Bergström U, Pikwer M, Nilsson JÅ, Jacobsson LT.

Arthritis Res Ther. 2015 Oct 12;17:284. doi: 10.1186/s13075-015-0804-1.


A high body mass index is associated with reduced risk of rheumatoid arthritis in men, but not in women.

Turesson C, Bergström U, Pikwer M, Nilsson JÅ, Jacobsson LT.

Rheumatology (Oxford). 2016 Feb;55(2):307-14. doi: 10.1093/rheumatology/kev313. Epub 2015 Sep 8.


Mortality in ankylosing spondylitis: results from a nationwide population-based study.

Exarchou S, Lie E, Lindström U, Askling J, Forsblad-d'Elia H, Turesson C, Kristensen LE, Jacobsson LT.

Ann Rheum Dis. 2016 Aug;75(8):1466-72. doi: 10.1136/annrheumdis-2015-207688. Epub 2015 Sep 2.


Supplemental Content

Loading ...
Support Center